Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (IGF-1)
US-2018016340-A1 · Jan 18, 2018 · US
This page is not indexed by search engines while we improve data quality.
Clemmons David patents
Clemmons David is listed as an inventor on 5 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Clemmons David |
| Total patents | 5 |
| First publication | Jul 7, 2015 |
| Latest publication | Jan 18, 2018 |
Notable patents
Publications ranked by popularity score, then publication date.
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)
US-9587024-B2 · Mar 7, 2017 · US
Compounds and methods for treating obesity and controlling weight
US-2016039897-A1 · Feb 11, 2016 · US
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor I (IGF-1)
US-2015259422-A1 · Sep 17, 2015 · US
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)
US-9073996-B2 · Jul 7, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ North Carolina | 3 |
| Univ North Carolina Chapel Hill | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.